Cargando…
Discovery of Novel Soluble Epoxide Hydrolase Inhibitors as Potent Vasodilators
In view of the role of sEH (soluble epoxide hydrolase) in hypertension, we have developed a rigorously validated pharmacophore model containing one HBA (Hydrogen Bond Acceptor), two HY (Hydrophobic) and one RA (Ring Aromatic) features. The model was used as a query to search the NCI (National Cancer...
Autores principales: | Tripathi, Neetika, Paliwal, Sarvesh, Sharma, Swapnil, Verma, Kanika, Gururani, Ritika, Tiwari, Akanksha, Verma, Amrita, Chauhan, Monika, Singh, Aarti, Kumar, Dipak, Pant, Aditya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168526/ https://www.ncbi.nlm.nih.gov/pubmed/30279487 http://dx.doi.org/10.1038/s41598-018-32449-4 |
Ejemplares similares
-
An Insight on Multicentric Signaling of Angiotensin II in Cardiovascular system: A Recent Update
por: Verma, Kanika, et al.
Publicado: (2021) -
Simvastatin ameliorates oxidative stress levels in HepG2 cells and hyperlipidemic rats
por: Verma, Kanika, et al.
Publicado: (2022) -
Selection of Potent Inhibitors of Soluble Epoxide Hydrolase for Usage in Veterinary Medicine
por: Shihadih, Diyala S., et al.
Publicado: (2020) -
Pharmacophore-driven identification of N-methyl-D-receptor antagonists as potent neuroprotective agents validated using in vivo studies
por: Sharma, Mukta, et al.
Publicado: (2020) -
Soluble Epoxide Hydrolase in Atherosclerosis
por: Wang, Yi-Xin Jim, et al.
Publicado: (2010)